Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hospira Targets First U.S. Biosimilar Filing In 2014

Dec 10 2013

• By Jessica Merrill

Related Content

Korea's Celltrion In Deal With U.S.-based Hospira For Biogeneric Sales; M&A Hinted At

Oct 12 2009

On The Cusp Of Biosimilars: Reform Ushers In Next Generic Drug Era

Mar 29 2010

Related Companies

Hospira, Inc.

Amgen, Inc.

Johnson & Johnson

Celltrion, Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

Roche Holding AG

AbbVie Inc.

Pfizer Inc.

Additional Topics

Europe United States Business Strategies Launches BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window